for patients enrolled in ongoing clinical trials, effectively cutting off access to the first new Alzheimer’s drug in nearly two decades, which the Food and Drug Administration approved in June despite conflicting trial results. The preliminary decision applies not only to Aduhelm, but the whole class of similar drugs, many of which are in development.
While the various supporters of broader access have not yet coalesced around a single strategy, broad outlines of a plan are already becoming clear. “On the Hill, a lot of people care about Alzheimer's,” Vradenburg said. “There will be letters. There’ll be meetings. There’ll be everything we can muster to turn that decision around.”
It is rare but not unheard of for CMS to change trial participation requirements between a draft and final coverage decision. In 2019, CMS proposed requiring hospitals administering CAR-T therapies to track patients in observational studies. Hospitals complained it was too burdensome and CMS relented.CMS’ requirements for Aduhelm are even more burdensome, said John Dwyer, president of the Global Alzheimer's Platform Foundation.
Misinformation is how we got here. Misinformation about the vaccine. Misinformation about the virus Misinformation about masks. Misinformation is the new truth on fox news and all the other's that helped spread the misinformation just to make money with no care about people. GOP
THERE ISN'T DATA THAT SAYS THIS DRUG WORKS. HECK, THEY DON'T PAY FOR A LOT OF CANCER DRUGS THAT HAVE A BETTER TRACK RECORD AND MORE DATA THAN THIS DRUG EITHER.
RAPE_Culture Offshore Leaks2013 ChinaLeaks2014 Panama Papers2016 Bahamas Leaks2016 Football_Leaks2016 Money Island2017 MaltaFiles2017 Paradise Papers2017 Dubaï Papers2018 FinCENFiles2020 OpenLux2021 PandoraPapers2021 =LESS educational-SANITARY-democratic-ECOLOGICAL projects
It ain’t working
And politicians making record money on their investments
It ain’t working for everyone
There’s no evidence that it provides any benefit
It is time for POTUS TheDemocrats to keep their word and CancelStudentDebt - our families need these resources for our children and aging parents! Generational wealth and a light pigmentation cannot be our only means of attaining upward mobility and educational aspirations.
stop ALS
so wait.. they're mad because it's not really proven to work, AND it's limited to be available. Sounds like that's the whole point. to NOT provide drugs that don't work, that are at crazy high cost... What am i missing here.. ?
The cost of this drug is unconscionable especially given that it was approved under a bit of a shadow. The entity patient groups should go after is the drug maker
I, for one, am glad Medicare and Medicaid are asking for more data before covering this drug. It shouldn't have been given the green light to begin with and I, as a Medicare recipient, don't want to be on the hook to pay more to cover something of questionable efficacy.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CBS DFW - 🏆 542. / 51 Read more »
Source: BestLifeOnline - 🏆 533. / 51 Read more »
Source: motorauthority - 🏆 61. / 68 Read more »
Source: nypost - 🏆 91. / 67 Read more »
Source: axios - 🏆 302. / 63 Read more »
Source: trtworld - 🏆 101. / 63 Read more »